The ITIM receptor G6b-B is a critical regulator of megakaryocyte activation, platelet production and function
Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia a mice transplanted with genetically manipulated human cord blood stem cells
Nuclear factor (NF)-κB is a major regulator of blood induced joint damage in a murine model of hemophilia A
Structure of factor XI in complex with a high molecular weight kininogen peptide
Involvement of α2-antiplasmin in dendritic growth during memory formation
Modulation of TAFI-dependent regulation of fibrinolysis by extracellular histones
Tissue factor expressing neutrophils initiate coagulation on injured vessel walls
EGFP-EGF1 protein conjugated PEG-PLGA nanoparticles for cerebral thrombi targeting drug delivery
Loss of protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria
Extracellular histones are eliciting factors for DIC
Prevention of venous thromboembolism after an isolated, non-surgical below-knee injury. Benefit/risk of fondaparinux vs. low molecular weight heparin: the fondacast study
Multiple SNP testing improves risk prediction of first venous thrombosis
A randomized-controlled phase II trial of primary thromboprophylaxis with enoxaparin in cancer patients with elevated tissue factor bearing microparticles (the microtec study)
Indirect comparison of efficacy and safety of dabigatran's RE-LY, rivaroxaban's rocket-AF, and Apixaban's Aristotle trial in patients with non-valvular atrial fibrillation
Autoantibodies directed against domain I of beta2- glycoprotein I indicate an increased risk for thromboembolic events in patients with antiphospholipid antibodies. A prospective cohort study
Whole-exome sequencing identifies novel risk variants for thrombotic storm
A novel genetic variant of the cytosolic phospholipase A2 alpha associated with bleeding diathesis and duodenal ulcers in an Italian family
Novel MHC peptide- T cell receptor interfaces are necessary for inhibitor formation in mild/moderate haemophilia a secondary to mis-sense mutation genotypes
Spatial blood coagulation in the presence of anti-TFPI aptamer BAX499 in hemophilia a patients after fVIII infusion
The incidence of factor VIII inhibitors in severe haemophilia a following a major product switch in the UK: a prospective controlled study in 1214 previously treated patients
XAMOS: a non-interventional study comparing thromboprophylaxis using oral rivaroxaban with conventional regimens after major orthopaedic surgery of the hip and knee
Risk of thromboembolism, recurrent bleeding and death after warfarin interruption for gastrointestinal bleeding
Despite pharmacological equivalence, generic versions of enoxaparin may differ in their pharmacodynamic actions. Potential therapeutic implications
Perceived stress reduces the stability of vitamin K-antagonist treatment
One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The pro-laps pilot feasibility study
The safety and efficacy of inferior vena cava filters: the experience of the Ottawa hospital
Evaluation of a community pharmacy anticoagulation management service utilising point-of-care testing and online computerised decision support
Is there a greater role for thrombolysis in the acute management of deep vein thrombosis (DVT)? Review of the management and outcome of patients presenting with proximal DVT to a single UK centre over a 2-year period
Endogenous thrombin potential in patients with low intensity vitamin K antagonists treatment
Prophylaxis of postoperative venous thromboembolism: pursuit of a rational systematic approach
Safety and efficacy of bridging with low molecular weight heparins: a systematic review
Variance growth rate: a superior method to monitor oral anticoagulation therapy
European action on anticoagulation (EAA) evaluation of the UK national health service (NHS) improvement guidelines for ‘safety indicators’ in anticoagulation of atrial fibrillation (AF)
Infrequent removal of retrievable IVC filters
Prediction of optimal warfarin maintenance dose using advanced artificial neural networks
Emergency reversal of vitamin K antagonists with prothrombin complex concentrate: the everyday practice
Biosimilar enoxaparins available for clinical use in Brazil: structure and haemostatic effects
Dabigatran experience in New Zealand
Role of sulfated galactans on thrombosis and antithrombin interaction
Developing an iphone app for the management of the anticoagulant dabigatran
The role of LMWH in prevention of deep veins thrombosis and pulmonary emboism in patients with severe multiple trauma
Fibrin formation under flow on biomimetic tissue factor rich surfaces
Pre-analytical routines in coagulation testing: are guidelines followed?
The atomic force microscopy a suitable technique to characterize procoagulant vesicles in the nanometer scale
Influence of dabigatran on coagulation assays, an ‘ in vitro’ study
Recommendations for laboratory testing of new anticoagulants in The Netherlands
Development of a novel imaging technique for the quantification of mass, volume, and density of thrombus formation
ADAMTS13 in von Willebrand factor (VWF) concentrates: is an intact VWF triplet structure important for VWF function?
SMIA: a new approach in FVIII inhibitor measurement and standardisation
Thrombin inhibition activity and in vitro stability in human plasma of two aptamers
Technoclot® DTI and Technoview® dabigatran - evaluation of assay performance monitoring the direct thrombin inhibitor dabigatran
Technochrom anti-Xa and technoview rivaroxaban - evaluation of assay performance on different analyzers
Staphylothrombin-mediated fibrin facilitates s. aureus-platelet interactions
Acute phase proteins reduce histone-induced platelet aggregation and coagulation activation
CTP - a clinically validated technology for elongating the half life of coagulation factors, enabling a prolonged haemostatic activity in hemophilic animal model
Influence of crystalloid diluents concentration on thrombin generation: comparison of nacl and mannitol
Spatial fibrin clot formation in plasma induced by surface-immobilized tissue factor: assay development and standardization
Interim results from a german prospective post-marketing surveillance of treatment of von Willebrand's disease with a new generation VWF/FVIII concentrate
impact of thrombin and FXA inhibitors (daigatran, apixaban, and rivaroxiban) on PT/APTT assays on IL instrument/reagent systems
Structure of the FXII protease domain
Influence of VKA, UFH or LMWH treated plasma in rivaroxaban measurement with different methods based on FX or FXA activity
Pharmacodynamic of bovine and porcine heparins
Semuloparin and it's component oligosaccharides release endogenous tfpi in a molecular weight dependent fashion. pharmacodynamic implications
Differentiation of newer oral anti-Xa and anti-IIa agents with a reference to the regulatory functions of thrombin
Comparison of the anticoagulant and antithrombotic activities of fucosylated chondroitin sulfate with the direct thrombin inhibitor dabigatran etexilate
Standardization of rotation thromboelastometry (Rotem®): evaluation of recombinant factor viii products in a multi-national clinical trial
The condensed MCMDM-1 VWD bleeding questionnaire as a predictor of bleeding disorders in women with unexplained menorrhagia
Genetic defects in von Willebrand disease Type 3 in South West Iran
Octanate shows low inhibitor incidence in treatment of previously untreated patients with haemophilia A
The effect of CPB on FXIII levels in children
Dysfibrinogenemia caused by two mutations present in a single chromosome
Determination of fibrinogen level to guide replacement therapy in patients undergoing cardiopulmonary bypass with direct thrombin inhibitors
How do haemostatic variables affect thrombin generation during the course of the menstrual cycle?
Detecting interaction of VWF A1 domain and A3 domain using snap/clip-tag technology
Influence of temperature on fibrin clot formation process in thrombodynamics and routine clotting tests
ITI with a VWF-stabilised FVIII concentrate in haemophilia a patients with inhibitors and a poor prognosis for ITI success: progress report on octanate in the observational obsiti study
Evaluating the precision and accuracy of the laboratory measurement of anti-porcine factor VIII antibodies
Tissue factor, a potent stimulator of cultured endothelial cells
Quantification of menorrhagia in women with von Willebrands disease and rare bleeding disorders
Study of the efficacy of routine use of rectal misoprostol in the prevention of post-partum haemorrhage in rural Nigeria
Frequency of factor XIII deficiency amongst patients with rare bleeding disorders in pakistan: a multicenter experience
Do haemostatic parameters vary during the course of the menstrual cycle?
How do female hormone levels affect the haemostasis during the course of the menstrual cycle?
Coagulation and fibrinolytic parameters in Nigerian type 2 diabetics with microvascular complications
Coagulation markers and reheology profiles in some Nigerian pregnant women
Immune tolerance therapy in children with FVIII inhibitors: progress report
Effective target thrombolysis mediated by recombinant tissue plasminogen activator-conjugated nanoparticles
Alpha2-antiplasmin regulates the development of fibrosis by Pgf2α synthesis through Atgl/Ipla2
Reduced fibrinolytic response to tissue plasminogen activator demonstrated by thromboelastography in a patient with hypo-dysfibrinogenemia and a novel fibrinogen mutation
Effect of dabigatran and rivaroxiban on thrombomodulin mediated activation of protein c and thrombin activated fibrinolysis inhibitor (TAFI)
The anticoagulant effect of bromelain: an in vitro study using thromboelastography
D-dimer level, factor XII activity and XIIA-dependent fibrinolysis in normal pregnancy
Technical and clinical validation of a modified thromboelastometry approach on a rotem device for the identification of patients at risk for hypo- and hyperfibrinolysis
B cell-derived vascular endothelial growth factor a promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes
Roles for transglutaminase 2 and blood clotting factor XIII-A in the maintenance of blood vessel structure
Relationship of platelet microparticles to complications and outcome of acute liver injury/acute liver failure (ALI/ALF)
Activated protein C (APC) and thrombin modulate cardiomyocytes contractility via a protease activated receptor -1 (PAR1)- cardiac troponin I (CTI) pathway
Nitric oxide from enos reduces abdominal aortic aneurysms development in a mouse model with human-like hypercholesterolemia
Cilostazol improves an accumulation of Aβ by LRP-1 expression on endothelial cells
Procoagulant phospholipids activity in cerebrospinal fluid from patients with intracerebral haemorrhage
Cleaved high molecular weight kininogen stimulates JNK/FOXO/MNSOD pathway for induction of endothelial progenitor cell senescence
Is prothrombin time a predictor of new-onset diabetes in hypertensive and coronary heart disease patients?
Thrombin generation on endothelial cells is initiated by both intrinsic and extrinsic activation and should be carried out in low serum conditions
The research of inter-relationship between ADAMTS13 and human microvascular endothelial cells
Analysis of synthetic and biological microparticles on several flow cytometric platforms
Standardization of flow cytometry-based microparticle analysis for cytometers using side scatter for size measurements
The angiogenesis and anti-fibrosis effects of human adipose-derived stem cells overexpressing human HGF on acute myocardial infarction
Factor XIII in haemophilia a - effect on clot structure and permeability
Factor γ A1 domain substitution HIS99ARG results in super-instability of factor γ and discrepancy between one-stage and two-stage Fγ:C assay in a mild hemophilia A patient
Use of next-generation DNA sequencing for gene discovery in bleeding syndromes with defects of platelet function: a pilot study
Head-to-head comparison of the optimul assay (96-well plate aggregometry) with gold standard light transmission aggregometry for detection of acquired and inherited platelet defects
Hemostatic properties of red cell derived microparticles (RMP): promise of universal hemostatic agent
FVIII:C assay discrepancy and genotype-phenotype correlation in a group of mild haemophilia a patients
Development of an alternative assay for the assessment of factor VIII inhibitor Bethesda titres
Genetic analysis of twenty Egyptian patients with congenital afibrinogenemia
Mutations causing severe factor XIII deficiency in Pakistan
VWF exerts a protective effect on FVIII from inhibitor inactivation both in vitro and in vivo
von Willebrand Factor Propeptide (VWFPP) to von Willebrand factor antigen (VWF:AG) ratio in different subtypes of congenital and acquired von Willebrand disease (VWD)
Combined APTT and waveform analysis increases the diagnostic capability of standard APTT assays
Presentation and management of acute coronary syndromes (ACS) among adult persons with hemophilia (PWH): initial results of an international, retrospective, ten-year survey
Fluorescent quantitation PCR method applied to do carrier and prenatal diagnosis in haemophilia A and B families with large deletion mutations
Thrombin generation, thrombodynamics and thromboelastography in the patients with different bleeding phenotype of severe hemophilia A
Genetic defect of F9 gene and polymorphisms in immune response genes associated with high titer inhibitor development and anaphylaxis in one hemophilia B case
Maternal heterodisomy/isodisomy of chromosome 4 in a child with congenital afibrinogenemia containing a novel TRP293X mutation in fibrinogen BB-chain gene
Differences in exposure of the domain i epitope of beta2-glycoprotein i in commercial elisa kits for the diagnosis of the antiphospholipid syndrome
Measurement of anti-ADAMTS13 neutralising autoantibodies: a comparison between CBA and fret assays
Modeling physiological and cytokine data to predict outcome
Predictive value of high factor VIII levels for recurrent venous thrombosis
Acustar HIT-IGG and heparin-induced multiple electrode aggregometry: a useful combination for rapid diagnosis of type-II HIT
Determination of dabigatran in plasma, serum, and urine samples from patient with atrial fibrillation
Determination of rivaroxaban in plasma, serum, and urine from patients undergoing total hip and knee replacement surgery
Prevalence of factor V Leiden in 318 iranian individual referred cases and the diagnostic power of two different APC-R screening tests
Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study
Preanalytical variables of the calibrated automated thrombogram: towards a standardized and validated procedure
Laboratory monitoring techniques for dabigatran and rivaroxaban - method suitability and variability between European laboratories
In vitro assessment of the applicability of prothrombin complex concentrate as antidote for the direct factor XA inhibitor rivaroxaban
Validation of two age adapted d-dimer cut-off values for exclusion of deep venous thrombosis in suspected elderly primary care patients
The cost-effectiveness of ‘point of care’ D-dimer tests to rule out deep venous thrombosis in primary care
Fibrin-related marker comparison in sepsis: correlation to global and molecular parameters of haemostatic dysfunction
Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation
Laboratory recommendations for the monitoring of rivaroxaban
Laboratory recommendations for the monitoring of dabigatran
Comparison of prothrombinase-based apc resistance assay and FV Leiden genotyping
Evaluation of Pro C global assay as a screening test for thrombophilia in women with adverse pregnancy outcome
Thrombodynamics assay in healthy and diseased subjects
Characterization of the role of cancer cells in the promotion of thrombus formation under shear
Prolonged clot lysis time is a risk factor for venous thrombosis
Lyophilized normal and abnormal lupus control plasma can be used for assay control in DRVV and APTT based lupus anticoagulant tests
von Willebrand factor level in newly diagnosed patient with multiple myeloma after the first cycles of induction therapy
Unfractionated heparin (UFH) and low molecular weight heparins (LMWH) counteract thrombin generation (TG) and proangiogenic properties of MDA.MB.231 breast cancer cells
The European action on anticoagulation (EAA) prothrombin time /international normalised ratio (PT/ INR) line - a rapid method of deriving local international sensitivity index (ISI) and mean normal PT (MNPT) for use with coagulometers
European action on anticoagulation (EAA). local INR derivation simplified by the PT/INR line and a spreadsheet from the world wide web
Characterization of thrombin generation (TG) by the calibrated automated thrombography (CAT) in atrial fibrillation (AF) patients on permanent oral anticoagulation therapy (OAT) with warfarin
The effect of preanalytical and analytical variables on spatial fibrin clot formation (the thrombodynamics assay) in healthy subjects
Assessment of haemostasis in the primary multiple myeloma patients using different laboratory methods
Inhibitory effects of bortezomib on platelet aggregation induced by ADP, collagen and ristocetin in patients with multiple myeloma
Comparison of the use of TFPI blockage and plasma dilution to increase the sensitivity of thrombin generation assay to measure the procoagulant activity of microvesicles
Lupus anticoagulant screen and confirm reagents utilizing the FX activating venom from vipera lebetina
Correlation of peak thrombin results obtained by TGA measurement on Ceveron® alpha tga using fast setting and standard setting
Impact of CYP3A4*1G Polymorphism on plasmatic concentration profile of rivaroxaban (Xarelto®) assessed by coagulation assays
Discoid platelet aggregations without endothelium disruption visualized by in vivo molecular imaging, and contribution of inflammatory cytokines
Rapid recruitment and microaggregate formation of human platelets by the colonizing bacterium streptococcus oralis under shear rates that mimic physiological conditions
Three dimensional reconstruction of intact human integrin alphaiibbeta3 in a phospholipid bilayer nanodisc
Platelet flow-induced protrusion (FLIPR) formation is a shear and calpain induced process leading to platelet disintegration and the formation of procoagulant microparticles
Synergy of platelet receptors in thrombus formation: a microarray approach
Depletion of platelets in B16/F10 melanoma tumor bearing mice prevents maturation of newly formed tumor blood vessels
Exacerbation of GPVI-dependent platelet responses in a rhesus monkey model of type I diabetes
A new microfluidic point-of-care test for multi-shear platelet thrombosis
Nitric oxide enhances the anti-inflammatory and antiatherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis
Morpho-functional charactarization of platelets by atomic force microscopy
Shorter carotid artery occlusion in a thalassemic mouse model: a potential role for oxidative stress affecting both rbcs and platelets
Isothermal titration calorimetry confirms proteinprotein interactions in the human platelet
Two types of phosphatidylserine-expressing platelets are formed upon physiological activation and are controlled by integrin αlphaiib beta3 signaling
Molecular mechanisms involved in the antithrobotic activity of aegyptin, a novel mosquito-derived collagen-binding protein
Comparison of the new flow cytometric bead assay for VASP-Phosphorylation to a commercially available test in assessment of platelet inhibition by P2Y12 antagonists
Multiplate analyzer as a valid tool for platelet (PLT) aggregation studies in acid-citrate-dextrose (ACD) donor blood bags
Changes in platelet (PLT) aggregation and activation status during storage in platelet concentrates (PC) for transfusion use
Evaluation of baboon platelet aggregation in a Multiplate® platelet function analyzer
A mutation in ANKRD18A, ankyrin repeat domain 18A, causes a severe form of congenital thrombocytopenia
Acquiring an ‘inherited’ thrombocytopenia: clonal chromosome anomalies affecting FLI1 mimic inherited thrombocytopenia of the Paris-trousseau type
Sticky platelet syndrome and the genetic variability of the glycoprotein 6 gene in patients with venous thrombosis and pulmonary embolism
Identification of 61 novel mutations in the ITGA2B and ITGB3 genes of 90 patients with glanzmann thrombasthenia: an analysis of structure-function relationships
Platelet surface high mobility group box protein-1 binds receptor for advanced glycation endproducts in plasma or on monocytes in septic patients
A novel mechanism of P-selectin independent monocyte-platelet aggregation in children
A novel D235Y mutation in the GP1bA gene enhances platelet interaction with VWF in an Iranian family with platelet type von willebrand disease
Macrothrombocytopenia associated with phytosterolemia: a potential new platelet disorder
Pretreatment ADAMTS13 antibody concentration and age predicts relapse in patients with newly diagnosed acquired thrombotic thrombocytopenic pupura (TTP)
Anti-platelet medication for the progressing stroke with small vessels occlusion
A novel platelet assay that measures the effect of clopidogrel in vivo
Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion
Utility of teg and flowcytometry to guide platelet transfusion requirement in patients with haematological malignancies
Hemorrhagic risk due to platelet dysfunction in myelodysplatic patients. The correlations with anemia severity and iron overload
Preoperative bleeding risk factors in TAVI patients
Tolerability and efficacy of romiplostim as management of severe, refractory immune thrombocytopenia (ITP) during pregnancy
Evaluation of platelet dysfunction in viral liver disease: relationship to disease severity
Relationship between von Willebrand factor and platelet parameters in adult dengue infection patients
Thrombin generation test in the monitoring of antiplatelet therapy effectiveness
Thromboelastographic testing to determine individual response to clopidogrel
Effect of cytochrome P450 polymorphism on platelet reactivity after treatment with clopidogrel in patients scheduled for percutaneous coronary intervention
Markers of coagulation and inflammation in relation to the post thrombotic syndrome
Alternative diagnoses of pulmonary embolism in primary care
Compliance of recommendations with french clinical practice in the management of thromboembolism in patients with cancer: the Carmen study
D-Dimer and ultrasound in combination Italian study (dulcis) to establish the optimal duration of anticoagulation for venous thromboembolism: preliminary results
Unusual thromboses and thrombophilia: a case-control study
Micropartical-associated thrombin generation in patients with postthrombophlebitic syndrome
One year event rate of serious thrombosis and bleeding in Japanese patients with myocardial infarction, stroke and atrial fibrillation
The value of D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease: a systematic review
Venous thromboembolism prophylaxis in elderly patients admitted to Italian internal medicine wards
Readmission and death rates from venous thromboembolism within 90 days of hospital admission: what can we learn from measuring real outcomes at a national level?
Coffee consumption and a reduced risk of venous thrombosis: mediated through hemostatic factors
Venous thrombosis in a patient with congenital afibrinogenemia: clinical implications and management
Acquired and genetic risk factors assessment for deep venous thrombosis in 389 of hospitalized Chinese patients: a single center experiences
Quality of life in acute deep vein thrombosis and pulmonary embolism
Explicit assessment of thromboembolic risk and prophylaxis for medical patients in Switzerland (estimate): preliminary results
Prophylaxis guidelines as assessed retrospectively on a cohort of hospital-acquired venous thrombosis medical patients without thromboprophylaxis
Significance of tissue factor-positive microparticles in the patients with acute promyelocytic leukemia
Significantly higher level of lipoprotein (a) among acute coronary syndrome (ACS) than stable angina pectoris (SAP) patients or healthy subjects in Indonesian population
IL-18 and vascular mineralization in coronary artery disease patients
Study on gene markers of thrombosis in coronary heart disease by multi-analyte suspension array technology
Results from the national registry of thrombophilic states in Slovakia
Venous thromboembolism: a refined United States cost model with long-term attack rates
Coagulation factor XIII-B His95ARG polymorphism and the risk of coronary artery disease in a Croatian population
No correlation between mean platelet volume and the risk of recurrent venous or arterial thrombosis in patients with antiphospholipid syndrome
Developing animal models of hemolytic uremic syndrome
Complications associated with picc insertion in a hospital for high level of complexity of the city of medellin - Colombia
Using haemostatic and rheologic factorials as diagnostic and prognostic markers of acute myocardial infarctions in Nigerians
Novel hemostatic markers for thromboembolic risk in patients with prostate cancer
Fibrinogen-like protein 2 (FGL-2) - a novel biomarker for cancer
Case series: patients with JAK2 positive myeloproliferative neoplasms associated with thrombotic events
Fibrinogen, C-reactive protein and interleukin-6 in prediction of cardiovascular complications and death in type 2 diabetes: the advance study
The association of smoking with venous thrombosis and its modification by hormone replacement therapy
Long term follow up of homozygote protein c deficiency following multi modal therapy
Administration of antithrombin concentrate in infants and children on ECLS improves anticoagulation
Clinical findings in a prospective cohort of women in childbearing age with thrombosis and/or pregnancy adverse outcomes
Anticoagulation of cardiomyopathy in children
Predicting deep venous thrombosis in pregnancy: external validation of the ‘left’ clinical prediction rule
The economic costs of routine inr monitoring in infants and children
Cerebral te in Italian infants and children: data from the Italian registry of childhood thrombosis (RITI)
Prospective study on incidence rate of neonatal and pediatric thromboembolism in a single tertiary care hospital in Italy during a 5-year period
Obstetrics outcomes associated with an increased level of lipoprotein-a (LP-a) in thrombophilic patients
Molecular basis of type I antithrombin deficiency in two women with recurrent venous thromboembolism in the first trimester of pregnancy
Higher doses of low molecular weight heparin (LMWH) are needed to achieve goal Anti-Xa levels in critically ill children
The effect of antithrombin concentrates on angiogenesis in seriously ill children
The prevalence and role of elevated coagulation factors VIII, IX and XI in arterial thrombosis in children
Assisted reproduction technologies failure and acquired thrombophilia: experience of a single specialized Argentinian center
Hereditary antithrombin deficiency and pregnancy
Venous thromboembolism in Italian infants and children: data from the italian registry of childhood thrombosis (RITI)
Thromboembolic complications in Italian infants and chidren: comparison of data from RITI registry with a single centre consecutive serie
Low levels of vitamin d in pregnant women with thromboembolism/thrombophilia
Placental abruption and thrombophilia
Pediatric thrombosis educational tool (P-TET): an educational project in development for children receiving oral anticoagulation
Thromboprophylaxis with two different dosages of lwmh (calcic nadroparin) in pregnant women with thrombophilia: a single center experience
The risk of venous thromboembolic during pregnancy
Detection of non inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:AG in von willebrand disease
Biochemical and molecular characterization of 10 Italians patients affected by von willebrand disease type 2A/IIE
Two cases of congenital thrombotic thrombocytopenic purpura associated with pregnancy
A new automated chemiluminescent method for the determination of von Willebrand factor ristocetin cofactor activity (VWF:RCO) and von willebrand factor antigen (VWF:AG)
Head-to-head comparative study of the pharmacokinetic behavior of a high-purity factor ix concentrate (alphanine®) and a recombinant factor ix (benefix®) in patients with severe hemophilia B
Genetic diagnosis in sporadic haemophilia a families in China
Prevalance and treatment outcome of transfusion transmitted infections in hemophilia A
The missing pieces for understanding fviii inhibitor development: hemophilia inhibitor pup study
Prenatal diagnosis for congenital factor VII deficiency: one case report
FXI deficiency: genotype-phenotype relationship
A machine learning approach to merging and analyzing data from the condensed MCMDM1-VWD bleeding questionnaire
P.E1549K: a new mutation responsible of von willebrand disease type 2M
P.M1304v: a new mutation in the A1 domain associated to atypical von Willebrand 2B phenotype
Comparison of recombinant FVIII utilisation in a cohort of UK patients following a switch from a full length to B-domain deleted FVIII: a retrospective analysis of homecare delivery data
Standardization of an APTT-based FVIII inhibitor screening assay
Inherited bleeding disorders in Pakistani women presenting with menorrhagia
Pharmacokinetics and safety profile of a single intravenous dose of recombinant factor XIII in paediatric patients with congenital factor XIII a-subunit deficiency
Pharmacokinetics of a new RFVIII, turoctocog alfa, in adult/adolescent and paediatric patients with severe haemophilia A. data from the guardian™ 1 and guardian™ 3 trials
Effect of APTT reagent and standard on plasma-derived and recombinant factor IX potency estimates
Comparison of quality of life in an Amish and nonamish cohort affected with von willebrand disease